Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort
- Resource Type
- Article
- Source
- In
Clinical Microbiology and Infection April 2015 21(4):386-386 - Subject
- Language
- ISSN
- 1198-743X